Ming Xun Li

Address:

7816 147 St, Flushing, NY 11367

Phone:

7183805640

VIN:

4S4BRDLCXB2363873

Make:

SUBARU

Model:

OUTBACK

Year:

2011

US Patent:

6785846, Aug 31, 2004

Filed:

Dec 22, 2000

Appl. No.:

09/742372

Inventors:

Ming Y. Li - Mahwah NJ

Assignee:

Intel Corporation - Santa Clara CA

International Classification:

G06F 1100

US Classification:

714 30, 714 36, 714733

Abstract:

A system and method is provided for detecting defects in an embedded architecture or micro-processor based system. A look-up table, located with in a programmable logic device, is accessed to obtain a value for a particular byte of a predetermined data pattern. The predetermined data pattern is associated with data from a bus coupled to the programmable logic device. The accessed value of the predetermined data pattern is compared to data that is received by the programmable logic device from a memory coupled to the programmable logic device via the bus. An alarm mechanism, to indicate an improper data comparison, is triggered based upon the comparison of the predetermined data pattern and the data received from the memory.

US Patent:

8588810, Nov 19, 2013

Filed:

Nov 30, 2011

Appl. No.:

13/307754

Inventors:

Jing Dai - White Plains NY, US
Ming Li - Elmsford NY, US
Milind R. Naphade - Fishkill NY, US
Sambit Sahu - Hopewell Junction NY, US

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

H04W 24/00

US Classification:

4554561, 455 412, 4554042, 4554562, 4554563, 4554566

Abstract:

A GPS-enabled cellular electronic device is operated in an indoor mode. An increase in strength of a cellular signal is detected at the GPS-enabled cellular electronic device. Responsive at least to the increase in cellular signal strength, the GPS-enabled cellular electronic device is transitioned to an outdoor testing mode. Detecting is carried out to determine whether movement of the GPS-enabled cellular electronic device occurs during the outdoor testing mode. If so, the GPS-enabled cellular electronic device is transitioned to an outdoor mode.

US Patent:

20100227795, Sep 9, 2010

Filed:

Mar 3, 2009

Appl. No.:

12/397219

Inventors:

Solomon S. Steiner - Mount Kisco NY, US
Ming Li - Yorktown Heights NY, US
Robert Hauser - Columbia MD, US

International Classification:

A61K 38/28
A61P 3/10

US Classification:

514 3

Abstract:

Injectable insulin formulations with improved stability and rapid onset of action are described herein. The formulations may be for subcutaneous, intradermal or intramuscular administration. In the preferred embodiment, the formulations are administered via subcutaneous injection. The formulations contain insulin in combination with a chelator and dissolution agent, and optionally additional excipients. In the preferred embodiment, the formulation contains human insulin, a zinc chelator such as EDTA and a dissolution agent such as citric acid or sodium citrate. These formulations are rapidly absorbed into the blood stream when administered by subcutaneous injection. In the preferred embodiment, the insulin is provided as a clear liquid, neutral pH, in a multi-use sterile vial. In an alternative embodiment, the insulin is provided as a powder in a sterile vial. This is mixed with a diluent containing a pharmaceutically acceptable carrier, such as water, a zinc chelator such as EDTA and a dissolution agent such as citric acid shortly before or at the time of administration. In another embodiment, the insulin is stored as a frozen mixture, ready for use upon thawing.

US Patent:

20110097386, Apr 28, 2011

Filed:

Mar 1, 2010

Appl. No.:

12/715203

Inventors:

Solomon S. Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Ming Li - Yorktown Heights NY, US
Robert Feldstein - Yonkers NY, US

International Classification:

A61K 38/26
A61K 9/127
A61P 3/08

US Classification:

424450, 514 117

Abstract:

A formulation composed of a sugar such as glucose and a surfactant such as myristoyl lysophosphocholine (LMPC) has been designed to stabilize both hydrophilic and hydrophobic portions of the glucagon molecule, under prolonged physiological conditions, in a formulation that is sufficiently similar to the pH and osmolarity of plasma so as not to induce or to minimize site irritation. The combination of a simple sugar and an surfactant stabilizes the glucagon molecule in an aqueous solution for seven days at 37 C.

US Patent:

20110237510, Sep 29, 2011

Filed:

Sep 27, 2010

Appl. No.:

12/891240

Inventors:

Solomon S. Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Ming Li - Yorktown Heights NY, US
Robert Feldstein - Yonkers NY, US

International Classification:

A61K 38/26
A61P 3/08
B65D 85/00

US Classification:

514 117, 2065241

Abstract:

A formulation composed of a sugar such as glucose and a surfactant such as myristoyl lysophosphocholine (LMPC) has been designed to stabilize both hydrophilic and hydrophobic portions of the glucagon molecule, under prolonged physiological conditions, in a formulation that is sufficiently similar to the pH and osmolarity of plasma so as not to induce or to minimize site irritation. The combination of a simple sugar and an surfactant stabilizes the glucagon molecule in an aqueous solution for seven days at 37 C.

US Patent:

20120178675, Jul 12, 2012

Filed:

Jul 5, 2011

Appl. No.:

13/176435

Inventors:

Solomon Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Richard Seibert - Carmel NY, US
Ming Li - Yorktown Heights NY, US

International Classification:

A61K 38/28
A61P 25/00
A61P 3/10

US Classification:

514 64

Abstract:

Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of rapid acting injectable insulin formulations are described herein. In the preferred embodiment, the formulations are administered via subcutaneous injection. The formulations contain insulin in combination with a zinc chelator such as ethylenediaminetetraacetic acid (“EDTA”) and a dissolution/stabilization agent, and optionally additional excipients. Calcium disodium EDTA is less likely to remove calcium from the body, and typically has less pain on injection in the subcutaneous tissue. Modulating the type and quantity of EDTA can change the insulin absorption profile. Increasing the quantity of citrate can further enhance absorption and chemically stabilize the formulation. In the preferred embodiment, the formulation contains human insulin, calcium disodium EDTA and a dissolution/stabilization agent such as citric acid or sodium citrate. These formulations are rapidly absorbed into the blood stream when administered by subcutaneous injection.

US Patent:

20120191856, Jul 26, 2012

Filed:

Jan 26, 2011

Appl. No.:

13/014501

Inventors:

HAN CHEN - White Plains NY, US
Minkyong Kim - Scarsdale NY, US
Hui Lei - Scarsdale NY, US
Ming Li - Elmsford NY, US
Fan Ye - Yorktown Heights NY, US

Assignee:

INTERNATIONAL BUSINESS MACHINES CORPORATION - ARMONK NY

International Classification:

G06F 15/173

US Classification:

709226

Abstract:

A system and method are disclosed for an elastic and scalable publish/subscribe scheme. Subscription information is received at a dispatcher node. A plurality of matching nodes are selected in an overlay network to store the subscription information on a computer readable storage medium. Upon receiving an event at a dispatching node, at least one of the matching nodes with the stored subscription information is selected to process the event.

US Patent:

20120310758, Dec 6, 2012

Filed:

Jun 1, 2011

Appl. No.:

13/150350

Inventors:

Kun Bai - Elmsford NY, US
Ming Li - Elmsford NY, US
Leslie S. Liu - White Plains NY, US
Fan Ye - Ossining NY, US
Liangzhao Zeng - Mohegan Lake NY, US
Xinxin Zhu - Croton on Hudson NY, US

Assignee:

INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY

International Classification:

G06Q 30/00

US Classification:

705 23, 705 267, 705 2661

Abstract:

Techniques for guideline-based food purchase management are provided. The techniques include generating a personalized set of nutrition guidelines for a user, generating a user profile for the user, wherein the user profile comprises health information and nutrition preferences, and using the personalized set of nutrition guidelines and the user profile to generate a guideline-based shopping list for the user. Techniques for generating location-based food purchase guidance are also provided. The techniques include obtaining a shopping list of food items and a list of stores to be considered in connection with the food items on the shopping list, using the shopping list, list of stores, a store location map and inter-store routing guidance to generate an inter-store shopping route, and generating an in-store shopping route, for each of the stores in the inter-store shopping route, based on the shopping list, intra-store routing guidance and a floor plan for the store.